{"name":"Madhukar H. Trivedi, MD","slug":"madhukar-h-trivedi-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9GX0g0cFRSS1VHYklxQnNYWTQyZk9TOGNOV21pZmt6RWdfSk1Rbm9FZUFpbEFsRlpyeDVDVno5T09TRDFsQWVUY2NsTzNBM1BLNnpRRUc0NDRjNlRkQWlTMkluZVpqZw?oc=5","date":"2024-07-22","type":"pipeline","source":"Psychiatry Online","summary":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report - Psychiatry Online","headline":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TcWZTV1hpdU11dDdrNEN2MVpOejNUdU85cjlfbF9ad2hrUk41REhPanV3T0x3b05CR1pGYWFDcmd5SWNvVlJhWVBUNVF2cDd4eWY0ci1VbTVjelc2RnFv?oc=5","date":"2024-03-07","type":"trial","source":"nature.com","summary":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial | Molecular Psychiatry - natur","headline":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPLU1DQnMxTmo4RGJ2TzRld2VCMFB3amZfZ3F1ZWcwOHpPdENBNEVMcjFTYS1BZWNQQUtFWmZFYlJIaFZVSjFCUlFoSDVOd2VSN0xIZDd1MGhFc3RrTFg5NDBOM3paYlJzVmRidE0zN3lnblh1aVpTZVBGNW5hbEtKZ09aMUhKNGxMUkZBY0ZxWTVydzJWcWwzMmR1ZkZwQlJZdTExWGx3?oc=5","date":"2023-10-20","type":"pipeline","source":"Psychiatrist.com","summary":"Inadequate Response to Treatment in Major Depressive Disorder: Augmentation and Adjunctive Strategies - Psychiatrist.com","headline":"Inadequate Response to Treatment in Major Depressive Disorder: Augmentation and Adjunctive Strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBXdm9WTEpLR0djeElqaGFXUWpKNE5FWTFERzZhSUpUSEdkNlA4M0J5UkJuUHlpYXBZRWZZNC1mQXh4MUhmV0Rvc3hsY1dyeUM0UmlPUzJpalI3SWdDdHhqcw?oc=5","date":"2021-01-13","type":"pipeline","source":"NEJM","summary":"Bupropion and Naltrexone in Methamphetamine Use Disorder - NEJM","headline":"Bupropion and Naltrexone in Methamphetamine Use Disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE42OTNQZWQ5VFJ5eHpCTGg5dzBVUnRld0g5ZjZSQlJibmNoMU90SG5YbDFKcjBRaHJxUFFnemxGSzkydS1lYW85czA2TzUtZTdqNHFOOTdWRnczb3RVd0xkQlBHUFlYU1Zac1FsNzNLNFA?oc=5","date":"2019-09-20","type":"pipeline","source":"Psychiatry Online","summary":"Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression - Psychiatry Online","headline":"Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9tYTcwcURRN0hHRWtLSnp6V1laVmtLZS1lZXJ2RU9tbEEwazh0UlhmSkVDeXBRMFY5Z1FTYmdsZG0tRVF4ZTR5YW4yaVhlMDN0bXc5Z3U0LUVaN3hDN0tUSXItMDJSbHRZMGMyTA?oc=5","date":"2018-07-18","type":"pipeline","source":"Psychiatry Online","summary":"Experimental Therapies for Treatment-Resistant Depression: Deciding When to Go to an Unproven or Experimental Therapy - Psychiatry Online","headline":"Experimental Therapies for Treatment-Resistant Depression: Deciding When to Go to an Unproven or Experimental Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8wNWJFbkpoY3lmU3VCeFFiQWc1TENtVmdrUU55TWdNbnRzd2xTY3ZGLWJoSFF1QXJkOW1RMzNuOHlmbGRUOFhQMUIzaUIyS3RVTmpWNjlaNk8yQkpYWEpz?oc=5","date":"2018-05-01","type":"pipeline","source":"NEJM","summary":"Medication Augmentation after the Failure of SSRIs for Depression - NEJM","headline":"Medication Augmentation after the Failure of SSRIs for Depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFBQUmRYZFVOMWFpd3ZrdlMxWVpHaUdfZFduNzhmM0lvODF6NjgxSldYYlZmc3NkRmZ6bHRSTWNhN2tYR01fV1pHaE51T0U2dFBLV1A4UmF6T3hFTVVubjhRbGFKOTl5VEpBeU1V?oc=5","date":"2007-05-01","type":"pipeline","source":"Psychiatry Online","summary":"Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report - Psychiatry Online","headline":"Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DNkktaF84dHFma2RGc29mU1o4RXBZSUNZSnkwcGVmZ0hjdzNGcDkxc0E3THh1QjVOWlI4VW05UGZtOVZOTk9EZVcxLXhpTHk2SUtjWm1GZnZDOU9NTHYw?oc=5","date":"2006-03-23","type":"pipeline","source":"NEJM","summary":"Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression - NEJM","headline":"Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}